← Eichor
Condition: Oligodendroglial Tumor Synced from ClinicalTrials.gov · July 30, 2026

Recruiting studies: Oligodendroglial Tumor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of How Safe and Effective Tarlatamab is in Brain Cancers
Phase 2 · 1 location(s) · University Health Network, Toronto · NCT06776250Genetic and Electrophysiologic Study in Focal Drug-resistant Epilepsies
Phase N/A · 1 location(s) · Fondation Ophtalmologique Adolphe de Rothschild · NCT02890641SIMPLIFication of Care Pathways for Patients With Rare Brain Tumors Through Artificial Intelligence
NA · 2 location(s) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT06878469
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.